PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fondazione IRCCS Policlinico San Matteo Pavia.\', \'Fondazione IRCCS Policlinico S. Matteo; University of Pavia.\', \'Fondazione IRCCS Policlinico San Matteo Pavia; University of Pavia.\', \'Carlo Poma Hospital, ASST Mantova.\', \'Fondazione IRCCS Policlinico San Matteo Pavia; university of Pavia.\', \'Fondazione IRCCS Policlinico San Matteo Pavia, University of Pavia.\', \'Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3324/haematol.2020.261784
?:doi
?:hasPublicationType
?:journal
  • Haematologica
is ?:pmid of
?:pmid
?:pmid
  • 33256382
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.063
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all